1-201047518-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000069.3(CACNA1S):​c.4543+7G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.132 in 1,607,216 control chromosomes in the GnomAD database, including 16,484 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.19 ( 3453 hom., cov: 33)
Exomes 𝑓: 0.13 ( 13031 hom. )

Consequence

CACNA1S
NM_000069.3 splice_region, intron

Scores

2
Splicing: ADA: 0.00002208
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.367

Publications

16 publications found
Variant links:
Genes affected
CACNA1S (HGNC:1397): (calcium voltage-gated channel subunit alpha1 S) This gene encodes one of the five subunits of the slowly inactivating L-type voltage-dependent calcium channel in skeletal muscle cells. Mutations in this gene have been associated with hypokalemic periodic paralysis, thyrotoxic periodic paralysis and malignant hyperthermia susceptibility. [provided by RefSeq, Jul 2008]
CACNA1S Gene-Disease associations (from GenCC):
  • congenital myopathy 18
    Inheritance: AD, AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hypokalemic periodic paralysis, type 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • malignant hyperthermia, susceptibility to, 5
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • congenital myopathy
    Inheritance: SD, AR, AD Classification: STRONG Submitted by: Illumina, Genomics England PanelApp
  • hypokalemic periodic paralysis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 1-201047518-C-T is Benign according to our data. Variant chr1-201047518-C-T is described in ClinVar as Benign. ClinVar VariationId is 254838.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.345 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000069.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1S
NM_000069.3
MANE Select
c.4543+7G>A
splice_region intron
N/ANP_000060.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1S
ENST00000362061.4
TSL:1 MANE Select
c.4543+7G>A
splice_region intron
N/AENSP00000355192.3
CACNA1S
ENST00000367338.7
TSL:5
c.4486+7G>A
splice_region intron
N/AENSP00000356307.3
CACNA1S
ENST00000681874.1
c.4483+7G>A
splice_region intron
N/AENSP00000505162.1

Frequencies

GnomAD3 genomes
AF:
0.186
AC:
28224
AN:
152040
Hom.:
3446
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.350
Gnomad AMI
AF:
0.0274
Gnomad AMR
AF:
0.132
Gnomad ASJ
AF:
0.0948
Gnomad EAS
AF:
0.127
Gnomad SAS
AF:
0.0613
Gnomad FIN
AF:
0.146
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.125
Gnomad OTH
AF:
0.159
GnomAD2 exomes
AF:
0.127
AC:
31937
AN:
251082
AF XY:
0.121
show subpopulations
Gnomad AFR exome
AF:
0.359
Gnomad AMR exome
AF:
0.0733
Gnomad ASJ exome
AF:
0.0991
Gnomad EAS exome
AF:
0.133
Gnomad FIN exome
AF:
0.140
Gnomad NFE exome
AF:
0.126
Gnomad OTH exome
AF:
0.135
GnomAD4 exome
AF:
0.127
AC:
184448
AN:
1455058
Hom.:
13031
Cov.:
30
AF XY:
0.124
AC XY:
90034
AN XY:
724256
show subpopulations
African (AFR)
AF:
0.357
AC:
11893
AN:
33272
American (AMR)
AF:
0.0790
AC:
3529
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.0989
AC:
2582
AN:
26104
East Asian (EAS)
AF:
0.127
AC:
5056
AN:
39660
South Asian (SAS)
AF:
0.0649
AC:
5593
AN:
86118
European-Finnish (FIN)
AF:
0.139
AC:
7401
AN:
53398
Middle Eastern (MID)
AF:
0.106
AC:
608
AN:
5744
European-Non Finnish (NFE)
AF:
0.126
AC:
139572
AN:
1105884
Other (OTH)
AF:
0.136
AC:
8214
AN:
60180
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
7736
15471
23207
30942
38678
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5056
10112
15168
20224
25280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.186
AC:
28256
AN:
152158
Hom.:
3453
Cov.:
33
AF XY:
0.182
AC XY:
13548
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.350
AC:
14510
AN:
41472
American (AMR)
AF:
0.132
AC:
2015
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0948
AC:
329
AN:
3470
East Asian (EAS)
AF:
0.126
AC:
655
AN:
5184
South Asian (SAS)
AF:
0.0609
AC:
294
AN:
4826
European-Finnish (FIN)
AF:
0.146
AC:
1547
AN:
10592
Middle Eastern (MID)
AF:
0.0714
AC:
21
AN:
294
European-Non Finnish (NFE)
AF:
0.125
AC:
8531
AN:
68006
Other (OTH)
AF:
0.156
AC:
329
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1102
2204
3307
4409
5511
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
282
564
846
1128
1410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.146
Hom.:
6434
Bravo
AF:
0.195
Asia WGS
AF:
0.115
AC:
398
AN:
3478
EpiCase
AF:
0.119
EpiControl
AF:
0.122

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
Hypokalemic periodic paralysis, type 1 (2)
-
-
1
Congenital myopathy 18 (1)
-
-
1
Malignant hyperthermia, susceptibility to, 5 (1)
-
-
1
Malignant hyperthermia, susceptibility to, 5;C3714580:Hypokalemic periodic paralysis, type 1 (1)
-
-
1
not provided (1)
-
-
1
Thyrotoxic periodic paralysis, susceptibility to, 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
1.8
DANN
Benign
0.55
PhyloP100
-0.37
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000022
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2297905; hg19: chr1-201016646; COSMIC: COSV107453946; COSMIC: COSV107453946; API